Laxai Pharma Ltd (LAXAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 860 | 1,490 | N/A | 1,790 |
| Receivables | N/A | N/A | 3,940 | N/A | 0 |
| Inventories | N/A | N/A | 1,840 | N/A | 0 |
| Other current assets | 0 | 6,260 | 760 | 0 | 6,800 |
| TOTAL | $N/A | $7,120 | $8,030 | $N/A | $8,590 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 0 | 240 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 440 | 0 | 1,430 |
| TOTAL | $N/A | $N/A | $680 | $N/A | $1,430 |
| Total Assets | $N/A | $7,120 | $10,230 | $N/A | $10,030 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 1,000 | N/A | 0 |
| Accounts payable and accrued liabilities | 0 | 0 | 2,830 | 0 | 0 |
| Other current liabilities | N/A | N/A | 1,320 | N/A | 0 |
| TOTAL | $N/A | $3,830 | $5,190 | $N/A | $5,720 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 620 | N/A | 0 |
| Other Non-Current Liabilities | 0 | 710 | 130 | 0 | 0 |
| TOTAL | $N/A | $710 | $750 | $N/A | $N/A |
| Total Liabilities | $N/A | $4,550 | $5,950 | $N/A | $5,720 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | 90 | N/A | 0 |
| Retained earnings | N/A | N/A | -11,980 | N/A | 0 |
| Other shareholders' equity | 0 | 2,570 | -20 | 0 | 4,300 |
| TOTAL | $N/A | $2,570 | $4,280 | $N/A | $4,300 |
| Total Liabilities And Equity | $0 | $7,120 | $10,230 | $0 | $10,020 |